Danaher Corporation $DHR Position Boosted by Van Den Berg Management I Inc.

Van Den Berg Management I Inc. raised its stake in Danaher Corporation (NYSE:DHR) by 18.8% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 43,029 shares of the conglomerate’s stock after purchasing an additional 6,801 shares during the quarter. Danaher makes up 1.7% of Van Den Berg Management I Inc.’s holdings, making the stock its 21st largest position. Van Den Berg Management I Inc.’s holdings in Danaher were worth $8,196,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Danaher during the 2nd quarter worth $10,492,520,000. State Street Corp raised its holdings in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after acquiring an additional 472,608 shares during the period. Capital International Investors raised its holdings in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. Wellington Management Group LLP lifted its position in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after acquiring an additional 1,334,221 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of several research analyst reports. Evercore reaffirmed an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Royal Bank Of Canada increased their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Piper Sandler began coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Finally, Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Stock Up 0.3%

NYSE DHR opened at $216.41 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $152.13 billion, a PE ratio of 38.44, a PEG ratio of 2.69 and a beta of 0.78. The firm has a 50-day simple moving average of $199.46 and a 200 day simple moving average of $192.52. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.77 earnings per share. On average, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.